08 of Sept., 2022 – participation in the FACT-bridge 2022 Antithrombotic Therapy Forum.
D.G. Tovbin, D.N. Tarasov, A.N. Kovalenko made oral presentations from our company.
Home
The main activities of the "PharmaDiall" company are search, development, chemical synthesis, "in vitro" and "in vivo" testing, organization and performing the clinical trials (all phases) and patenting of new biologically active chemicals that can later turn into drugs.
News
05/22/2022 - participation in the 5-th Russian conference MedChem-Russia 2021
Dmitry Shulga made an oral presentation. Dmitry Tovbin participated in the round table "Ways to Accelerate the Implementation of Innovative Pharmaceutical Developments into Practice".
09.05.2022 new article published in Journal of Biomolecular Structure and Dynamics
Investigation of the tight binding mechanism of a new anticoagulant DD217 to factor Xa by means of molecular docking and molecular dynamics